X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Biocon Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs BIOCON LTD - Comparison Results

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE BIOCON LTD TTK HEALTHCARE/
BIOCON LTD
 
P/E (TTM) x 27.7 94.5 29.3% View Chart
P/BV x 6.1 7.7 79.3% View Chart
Dividend Yield % 0.5 0.2 295.6%  

Financials

 TTK HEALTHCARE   BIOCON LTD
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
BIOCON LTD
Mar-17
TTK HEALTHCARE/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs6631,162 57.1%   
Low Rs399483 82.7%   
Sales per share (Unadj.) Rs535.6194.6 275.3%  
Earnings per share (Unadj.) Rs15.934.4 46.3%  
Cash flow per share (Unadj.) Rs20.048.3 41.5%  
Dividends per share (Unadj.) Rs4.001.00 400.0%  
Dividend yield (eoy) %0.80.1 619.1%  
Book value per share (Unadj.) Rs137.6241.9 56.9%  
Shares outstanding (eoy) m7.77200.00 3.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.2 23.5%   
Avg P/E ratio x33.323.9 139.4%  
P/CF ratio (eoy) x26.517.0 155.7%  
Price / Book Value ratio x3.93.4 113.6%  
Dividend payout %25.12.9 863.0%   
Avg Mkt Cap Rs m4,127164,440 2.5%   
No. of employees `0001.79.2 18.5%   
Total wages/salary Rs m6077,470 8.1%   
Avg. sales/employee Rs Th2,436.74,213.9 57.8%   
Avg. wages/employee Rs Th355.2809.0 43.9%   
Avg. net profit/employee Rs Th72.5745.2 9.7%   
INCOME DATA
Net Sales Rs m4,16238,911 10.7%  
Other income Rs m611,571 3.9%   
Total revenues Rs m4,22340,482 10.4%   
Gross profit Rs m1979,795 2.0%  
Depreciation Rs m322,772 1.1%   
Interest Rs m30260 11.5%   
Profit before tax Rs m1978,334 2.4%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,616 4.5%   
Profit after tax Rs m1246,881 1.8%  
Gross profit margin %4.725.2 18.8%  
Effective tax rate %37.019.4 190.9%   
Net profit margin %3.017.7 16.8%  
BALANCE SHEET DATA
Current assets Rs m1,62940,477 4.0%   
Current liabilities Rs m1,05816,783 6.3%   
Net working cap to sales %13.760.9 22.5%  
Current ratio x1.52.4 63.8%  
Inventory Days Days3060 50.0%  
Debtors Days Days3483 40.5%  
Net fixed assets Rs m55645,073 1.2%   
Share capital Rs m781,000 7.8%   
"Free" reserves Rs m87847,377 1.9%   
Net worth Rs m1,06948,377 2.2%   
Long term debt Rs m15921,082 0.8%   
Total assets Rs m2,39993,942 2.6%  
Interest coverage x7.633.1 22.9%   
Debt to equity ratio x0.10.4 34.1%  
Sales to assets ratio x1.70.4 418.8%   
Return on assets %6.47.6 84.3%  
Return on equity %11.614.2 81.5%  
Return on capital %18.512.6 146.4%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3312,988 0.3%   
Fx outflow Rs m637,899 0.8%   
Net fx Rs m-305,089 -0.6%   
CASH FLOW
From Operations Rs m1276,400 2.0%  
From Investments Rs m-146-4,985 2.9%  
From Financial Activity Rs m22-1,775 -1.2%  
Net Cashflow Rs m3-473 -0.5%  

Share Holding

Indian Promoters % 65.4 40.4 161.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 3.7 8.4 44.0%  
FIIs % 5.2 10.7 48.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 19.9 129.6%  
Shareholders   12,723 109,995 11.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   MERCK LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Vedanta & Kotak Mahindra Top Losers(Closing)

Indian share markets ended marginally lower on Monday amid weak global cues. The BSE Metal index, however, lost 1.7 amid rising global trade war fears.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (4QFY18); Net Profit Up 43.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, TTK HEALTHCARE has posted a net profit of Rs 80 m (up 43.1% YoY). Sales on the other hand came in at Rs 1 bn (up 21.4% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jun 18, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS